共 50 条
- [4] Etirinotecan pegol: an option for late-stage breast cancer? LANCET ONCOLOGY, 2013, 14 (12): : 1149 - 1151
- [9] Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (02): : 127 - 127